Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Titan Pharmaceuticals Inc. (TTNP)

-OTC BB
0.82 Up 0.03(3.78%) Jul 11, 3:57PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 911   911   2,198   2,198  
Cost of Revenue -   -   -   -  
Gross Profit 911   911   2,198   2,198  
Operating Expenses
Research Development949  929  1,679  1,789  
Selling General and Administrative896  624  647  701  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (934) (642) (128) (292)
Income from Continuing Operations
Total Other Income/Expenses Net(870)433  (1,018)5,356  
Earnings Before Interest And Taxes(1,804)(209)(1,146)5,064  
Interest Expense -   -  (1) -  
Income Before Tax(1,804)(209)(1,145)5,064  
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,804)(209)(1,145)5,064  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,804) (209) (1,145) 5,064  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,804) (209) (1,145) 5,064  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.